| Literature DB >> 32932693 |
M Mohan Babu1, P Syam Prasad1, P Venkateswara Rao2, S Hima Bindu1, A Prasad1, N Veeraiah3, Mutlu Özcan4.
Abstract
Zirconium doped calcium phosphate-based bioglasses are the most prominent bioactive materials for bone and dental repair and regeneration implants. In the present study, a 8ZnO-22Na2O-(24 - x)CaO-46P2O5-xZrO2 (0.1 ≤ x ≤ 0.7, all are in mol%) bioglass system was synthesized by the conventional melt-quenching process at 1100 °C. The glass-forming ability and thermal stability of the glasses were determined by measuring the glass transition temperature (Tg), crystallization temperature (Tc), and melting temperature (Tm), using differential thermal analysis (DTA). The biological activity of the prepared samples was identified by analyzing X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy-energy dispersive spectra (SEM-EDS), before and after immersion in simulated body fluid (SBF) for various intervals of 0, 1 and 5 days, along with the magnitude of pH and the degradation of glasses also evaluated. The obtained results revealed that the glass-forming ability and thermal stability of glasses increased with the increase in zirconia mol%. The XRD, FTIR, and SEM-EDS data confirmed a thin hydroxyapatite (HAp) layer over the sample surface after incubation in SBF for 1 and 5 days. Furthermore, the development of layer found to be increased with the increase of incubation time. The degradation of the glasses in SBF increased with incubation time and decreased gradually with the increase content of ZrO2 mol% in the host glass matrix. A sudden rise in initial pH values of residual SBF for 1 day owing to ion leaching and increase of Ca2+ and PO43- ions and then decreased. These findings confirmed the suitability of choosing material for bone-related applications.Entities:
Keywords: P2O5-bioglass; SBF; hydroxyapatite; in vitro bioactivity; melt-quenching; zirconia
Year: 2020 PMID: 32932693 PMCID: PMC7560252 DOI: 10.3390/ma13184058
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
The Nominal bioactive glass (mol%) composition.
| Glass Code | ZnO | Na2O | CaO | P2O5 | ZrO2 |
|---|---|---|---|---|---|
| Z.1 | 8.0 | 22.0 | 23.9 | 46.0 | 0.1 |
| Z.3 | 8.0 | 22.0 | 23.7 | 46.0 | 0.3 |
| Z.5 | 8.0 | 22.0 | 23.5 | 46.0 | 0.5 |
| Z.7 | 8.0 | 22.0 | 23.3 | 46.0 | 0.7 |
The concentration of various ions in the simulated body fluid (SBF) solution.
| Ion Type | Na+ | K+ | Mg2+ | Ca2+ | Cl− | HCO3− | HPO42− | SO4− |
|---|---|---|---|---|---|---|---|---|
| Concentration (mM) | 142.0 | 5.0 | 1.5 | 2.5 | 148.8 | 4.2 | 1.0 | 0.5 |
| Human blood plasma | 142.0 | 5.0 | 1.5 | 2.5 | 103.0 | 27.0 | 1.0 | 0.5 |
Figure 1DTA analysis curves of ZrO2 doped bioglass samples Z.1, Z.3, Z.5 and Z.7.
Figure 2Variation of glass transition (Tg) as a function of ZrO2 (mol%) content (inset shows the thermal stability vs ZrO2 concentration).
Thermal properties of the ZrO2 containing bioglasses.
| Sample Code | ΔT (°C) |
| |||
|---|---|---|---|---|---|
|
| 262.21 (± 1.11) | 335.67 | 672.67 | 73.46 (± 0.45) | 0.22 |
|
| 271.10 (± 1.30) | 349.21 | 686.92 | 78.10 (± 0.38) | 0.23 |
|
| 280.40 (± 1.24) | 362.87 | 691.84 | 82.47 (± 0.43) | 0.25 |
|
| 301.15 (± 1.25) | 386.32 | 697.49 | 85.16 (± 0.35) | 0.27 |
Figure 3X-ray diffraction patterns of the bioglass samples after immersion in SBF (a) 0 day, (b) 1 day and (c) 5 days.
Figure 4FTIR absorption spectra from the glass surface: (a) 0 day before and after (b) 1 day, (c) 5 days’ immersion in several days in SBF.
Assignments of various bands from FTIR spectra of the bioglasses.
| Wavenumber (cm−1) | Assignments | References | ||
|---|---|---|---|---|
| 0 day | 1 day | 5 days | ||
| 506 | 555 | 557 | ~506 PO43− O–P–O bending vibrations/P–O amorphous | [ |
| ~555–557 HAp (PO34) | [ | |||
| 752 | 736 | 738 | ~752 P–O–P symmetric stretching | [ |
| 978 | 916 | 918 | ~978cm−1 P–O–P stretching vibrations | [ |
| - | 1126 | 1143 | PO2 symmetric stretching vibration | [ |
| - | 1265 | - | PO2− asymmetric group /P=O stretching vibration | [ |
| - | - | 1410 | –OH, hydroxyl carbonate group | [ |
| - | - | 1543 | –OH groups | [ |
| 1642 | 1650 | - | ~1642–1650 cm−1 stretching vibrations of P-O-H group | [ |
| 2382 | - | - | P–O–H group /CO32− and HCO3− groups | [ |
| - | 2998 | - | C–H stretching vibrations | [ |
| - | - | 3198 | C–H | [ |
| 3464 | 3414 | 3553 | ~3414–3464 H–O–H bond /CO32− and HCO3− | [ |
| ~3553 O–H symmetric stretching | [ | |||
Figure 5SEM micrograph and EDS analysis of the bioglass sample Z.5 magnifications: for (a) 0 day before and (b) 1 day, (c) 5 days after immersion in SBF solution.
Figure 6pH variation for all the bioglass samples after immersion in SBF solution.
Figure 7Weight loss of ZrO2 doped glasses after immersion in SBF for 1 day and 5 days.